_PRIVATE_LIMITED.webp)
Aspire Healthcare Pharma (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-07-2024
- Paid Up Capital ₹ 1.00 M
as on 05-07-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 110.07%
(FY 2023)
- Profit 122.59%
(FY 2023)
- Ebitda 129.25%
(FY 2023)
- Net Worth 159.88%
(FY 2023)
- Total Assets -29.48%
(FY 2023)
About Aspire Healthcare Pharma (India)
The Corporate was formerly known as Morningside Healthcare (India) Private Limited. The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Murali Raman, Gary Buckley, and Richard Condon serve as directors at the Company.
- CIN/LLPIN
U74999TN2019FTC127980
- Company No.
127980
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
12 Mar 2019
- Date of AGM
26 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aspire Healthcare Pharma (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murali Raman  | Director | 12-Mar-2019 | Current |
Gary Buckley  | Director | 26-Jul-2023 | Current |
| Richard Condon | Director | 06-Jan-2023 | Current |
Financial Performance of Aspire Healthcare Pharma (India).
Aspire Healthcare Pharma (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 110.07% increase. The company also saw a substantial improvement in profitability, with a 122.59% increase in profit. The company's net worth Soared by an impressive increase of 159.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aspire Healthcare Pharma (India)?
In 2023, Aspire Healthcare Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aspire Healthcare Pharma (India)?
Aspire Healthcare Pharma (India) has a workforce of 54 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aspire Healthcare Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspire Healthcare Pharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_LIMITED.webp){kind=small}
